{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:35:21Z","timestamp":1759332921617,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.imbio.2022.152205","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T13:11:51Z","timestamp":1646745111000},"page":"152205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"227","author":[{"given":"Li-Jun","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Si","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Shan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao-Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Rousseaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadi","family":"Khochbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imbio.2022.152205_b0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The genetics and mechanisms of T cell acute lymphoblastic leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.imbio.2022.152205_b0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol."},{"issue":"7380","key":"10.1016\/j.imbio.2022.152205_b0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.imbio.2022.152205_b0020","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"issue":"23","key":"10.1016\/j.imbio.2022.152205_b0025","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2016.71.8585","article-title":"Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study","volume":"35","author":"Bond","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152205_b0030","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11684-012-0224-4","article-title":"Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia","volume":"6","author":"Ma","year":"2012","journal-title":"Front Med."},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0035","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations","volume":"2","author":"Neumann","year":"2012","journal-title":"Blood Cancer J."},{"issue":"3","key":"10.1016\/j.imbio.2022.152205_b0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/bjh.12882","article-title":"Outcome for children and young people with Early T-cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003","volume":"166","author":"Patrick","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152205_b0045","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3324\/haematol.2015.141218","article-title":"An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study","volume":"101","author":"Bond","year":"2016","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.imbio.2022.152205_b0050","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.3324\/haematol.2019.225078","article-title":"Unique clinico-biological, genetic and prognostic features of adult early T cell precursor acute lymphoblastic leukemia","volume":"105","author":"Genesc\u00e0","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.imbio.2022.152205_b0055","first-page":"47","article-title":"Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia","volume":"360","author":"Gonzalez-Garcia","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"17","key":"10.1016\/j.imbio.2022.152205_b0060","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"Asnafi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0065","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2013-03-491092","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia","volume":"122","author":"Van Vlierberghe","year":"2013","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.imbio.2022.152205_b0070","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia","volume":"94","author":"Baldus","year":"2009","journal-title":"Haematologica"},{"issue":"26","key":"10.1016\/j.imbio.2022.152205_b0075","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol","volume":"27","author":"Mansour","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"34","key":"10.1016\/j.imbio.2022.152205_b0080","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.imbio.2022.152205_b0085","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.imbio.2022.152205_b0090","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/bcj.2013.31","article-title":"Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia","volume":"3","author":"Weng","year":"2013","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.imbio.2022.152205_b0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.imbio.2022.152205_b0100","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/leu.2012.26","article-title":"Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries","volume":"26","author":"Chen","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.imbio.2022.152205_b0105","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"Van Vlierberghe","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imbio.2022.152205_b0110","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood-2002-09-2913","article-title":"CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage","volume":"102","author":"Asnafi","year":"2003","journal-title":"Blood"},{"issue":"10230","key":"10.1016\/j.imbio.2022.152205_b0115","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute lymphoblastic leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.imbio.2022.152205_b0120","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1182\/blood-2015-08-661702","article-title":"Early T-cell precursor acute lymphoblastic leukemia\/lymphoma (ETP-ALL\/LBL) in adolescents and adults: a high-risk subtype","volume":"127","author":"Jain","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.imbio.2022.152205_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00127","article-title":"First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia","author":"Numan","year":"2018","journal-title":"JCO Precis Oncol."},{"issue":"4","key":"10.1016\/j.imbio.2022.152205_b0130","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clml.2019.09.608","article-title":"Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia","volume":"20","author":"Richard-Carpentier","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"6","key":"10.1016\/j.imbio.2022.152205_b0135","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1158\/2159-8290.CD-20-1465","article-title":"Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma","volume":"11","author":"Pullarkat","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.imbio.2022.152205_b0140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fped.2017.00258","article-title":"Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children's Research Hospital Approach","volume":"5","author":"Inaba","year":"2017","journal-title":"Front Pediatr."},{"issue":"5","key":"10.1016\/j.imbio.2022.152205_b0145","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3324\/haematol.2019.217687","article-title":"Dissecting molecular mechanisms of resistance to NOTCH1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts","volume":"105","author":"Agnusdei","year":"2020","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0150","doi-asserted-by":"crossref","first-page":"a000539","DOI":"10.1101\/mcs.a000539","article-title":"Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the \u03b3-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case","volume":"1","author":"Knoechel","year":"2015","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"issue":"12","key":"10.1016\/j.imbio.2022.152205_b0155","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT pathway inhibition overcomes IL7-induced glucocorticoid resistance in a subset of human T-cell acute lymphoblastic leukemias","volume":"31","author":"Delgado-Martin","year":"2017","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.imbio.2022.152205_b0160","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1158\/1078-0432.CCR-14-2888","article-title":"A Phase I\/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed\/Refractory Acute Lymphoblastic Leukemia","volume":"21","author":"Daver","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"25","key":"10.1016\/j.imbio.2022.152205_b0165","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s13287-021-02595-0","article-title":"CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?","volume":"12","author":"Safarzadeh Kozani","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"3","key":"10.1016\/j.imbio.2022.152205_b0175","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3324\/haematol.2018.192757","article-title":"CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia","volume":"104","author":"Naik","year":"2019","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0180","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41375-019-0548-z","article-title":"Daratumumab for eradication of minimal residual disease in high-risk advanced relapse of T-cell\/CD19\/CD22-negative acute lymphoblastic leukemia","volume":"34","author":"Ofran","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.imbio.2022.152205_b0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/bjh.16616","article-title":"At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII\/ECOG E2993 trial","volume":"191","author":"Ganzel","year":"2020","journal-title":"Br. J. Haematol."},{"issue":"9","key":"10.1016\/j.imbio.2022.152205_b0190","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/leu.2016.60","article-title":"MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study","volume":"30","author":"Matlawska-Wasowska","year":"2016","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.imbio.2022.152205_b0195","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/ijc.33527","article-title":"Deleterious point mutations in T-cell acute lymphoblastic leukemia: Mechanistic insights into leukemogenesis","volume":"149","author":"Roy","year":"2021","journal-title":"Int. J. Cancer"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:49:17Z","timestamp":1759250957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298522000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0171298522000316"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152205","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152205"}}